与QT间期延长相关的药物制剂。
Pharmacologic agents associated with QT interval prolongation.
作者信息
Olsen Keith M
机构信息
University of Nebraska Medical Center, Omaha, NE, USA.
出版信息
J Fam Pract. 2005 Jun;Suppl:S8-S14.
PMID:15938993
Abstract
Diverse classes of medications are associated with QT interval prolongation and expose patients to the risk of potentially fatal ventricular arrhythmias. Clinicians can minimize adverse events by avoiding prescription of multiple medications associated with QT interval prolongation in high-risk patients.
摘要
多种药物类别与QT间期延长有关，使患者面临潜在致命性室性心律失常的风险。临床医生可以通过避免为高危患者开具多种与QT间期延长相关的药物来将不良事件降至最低。
Zotero 插件